1887
Volume 2010, Issue 2
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

To define the demographic, clinical and laboratory features, methods of diagnosis and outcome, in patients with meningococcal meningitis in Qatar, records were reviewed retrospectively to 25 patients (21 male, 4 female; mean age 24 years) treated for meningococcal meningitis at the Hamad Medical Corporation (HMC) between 1992 and 2008). Most (88%) were expatriates. The most common presenting symptoms were fever, vomiting, headache and altered consciousness. Neck stiffness and impaired level of consciousness were the most common signs. Elevated WBC, elevated protein and low glucose in CSF were present in 95.6%, 84% and 80% of cases respectively. Positive CSF Grainstain showing gram negative diplococci and culture growing N. meningitidis in CSF and blood were seen in 64%, 44% and 72.7% of cases respectively. The most common serotypes were Groups A and W 13 5 accounting for 50% and 25% respectively. 15.8% of isolates were intermediately resistant to penicillin, while all were sensitive to ceftriaxone. One patient (4%) died and 24 (96%) survived. Six of those who survived developed neurologic sequelae. Meningococcal meningitis remains uncommon in Qatar but the incidence has increased markedly recently especially among expatriates. Because the clinical features of the disease are non-specific, a high index of suspicion is essential for early diagnosis. Empirical treatment with ceftriaxone in a patient with suspected meningococcal meningitis seems prudent to avoid an unfavorable outcome.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2010.2.9
2010-12-01
2019-10-21
Loading full text...

Full text loading...

References

  1. 1. Whitney   CG., , Farley   MM., , Hadler   J., , Harrison   LH., , Bennett   NM., , Lynfield   R., , Reingold   A., , Cieslak   PR., , Pilishvili   T., , Jackson   D., , Facklam   RR., , Jorgensen   JH., , Schuchat   A. . Active Bacterial Core Surveillance of the Emerging Infections Program Network. Decline in invasive pneumococcal disease after the introduction ofprotein-polysaccharide conjugate vaccine. . N Eng J Med . 2003; ;348: : 1737– 17310 .
    [Google Scholar]
  2. 2. Hausdorff   WP., , Hajjeh   R., , Al Mazrou   A., , Shibl   A., , Soriano-Gabarro   M. . Middle East & North Africa Vaccine-Preventable Diseases Regional Advisory Group. The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) Region - Current status and need. . Vaccine . 2007; ;25: : 1935– 1944 .
    [Google Scholar]
  3. 3. Bhatt   KM., , Bhatt   SM., , Mirza   NB. . Meningococcal meningitis. . EastAfr Med J . 1996; ;73: : 35– 39 .
    [Google Scholar]
  4. 4. Weichselaum   A. . Uber die Aetiologie derAkuten Meningitis Cerebrospinalis. . FortschrMed . 1887; ;5: : 573-583,620-626 .
    [Google Scholar]
  5. 5. Raghunathan   PL., , Bernhardt   SA., , Rosenstein   NE. . Opportunities for control of meningococcal disease in the United States. . Annu Rev Med.   2004; ;55: : 333– 353 .
    [Google Scholar]
  6. 6. Rosenstein   NE., , Perkins   BA., , Stephens   DS. . The changing epidemiology of meningococcal disease in the United States, 1992-1996. . J Infect Dis.   1999; ;180: : 1894– 1901 .
    [Google Scholar]
  7. 7. Anonymous . Control and prevention of serogroup C meningococcal disease: Evaluation and management of suspected outbreaks: Recommendations of the Advisory Committee on Immunization Preactice (AGP). . MMWR Morb Mortal Wkly Rep . 1997; ;46: : 13 .
    [Google Scholar]
  8. 8. Kaplan   SL., , Schutze   GE., , Leake   JA. . Multicenter surveillance of invasive meningococcal infections in children. . Pediatrics.   2006; ;118: : e979– e984 .
    [Google Scholar]
  9. 9. Harrison   LH., , Dwyer   DM., , Maples   CT., , Billmann   L. . Risk of meningococcal infection in college students. . JAMA.   1999; ;281: : 1906– 1910 .
    [Google Scholar]
  10. 10. Fischer   M., , Perkins   BA. . Neisseria meningitis Serogroup B: Emergence of the ET-5 complex. . Semin Pediatr Infect Dis . 1997; ;8: : 50– 56 .
    [Google Scholar]
  11. 11. Rosenstein   NE., , Perkins   BA., , Stephens   DS., , Popovic   T., , Hughes   JM. . Meningococcal disease. . N Engl J Med.   2001; ;344: : 1378– 1388 .
    [Google Scholar]
  12. 12. Al Mazrou   YY., , Al Jeffri   MH., , Abdalla   MN., , Elgizouli   SA., , Mishskas   AA. . Changes in epidemiological pattern of Meningococcal disease in Saudi Arabia. Does it constitute a new challenge for prevention and control. . Saudi Med J . 2004; ;25: : 1410– 1413 .
    [Google Scholar]
  13. 13. Balkhy   HH., , Memish   ZA., , Osoba   AO. . Meningococcal carriage among local inhabitants during the pilgrimage 2000-2001. . IntJAntimicrob Agents.   2003; ;21: : 107– 111 .
    [Google Scholar]
  14. 14. Bilukha   00., , Rosenstein   N. . Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). . MMWR Recomm Rep . 2005; ;54: RR-7 : 1– 21 .
    [Google Scholar]
  15. 15. Pace   D., , Pollard   AJ., , Meningococcal   A. . C, Y and W-135 polysaccharideprotein conjugate vaccines. . 2007; ;92: : 909– 915 .
    [Google Scholar]
  16. 16. Broome   CV. . The carrier state: Neisseria meningitidis. . JAntimicrob Chemother.   1986; ;18: SupplA : 25– 34 .
    [Google Scholar]
  17. 17. Gray   LD., , Fedorko   DP. . Laboratory diagnosis of bacterial meningitis. . Clin Microbiol Rev . 1992; ;5: : 130– 145 .
    [Google Scholar]
  18. 18. Carpenter   RR., , Petersdorf   RG:. . The clinical spectrum of bacterial meningitis. . Am J Med . 1962; ;33: : 262– 275 .
    [Google Scholar]
  19. 19. Seward   RJ., , Towner   KJ. . Evaluation of a PCR-immunoassay technique for detection of Neisseria meningitidis in cerebrospinal fluid and peripheral blood. . J Med Microbiol . 2000; ;49: : 451– 456 .
    [Google Scholar]
  20. 20. Richter   SS., , Gordon   KA., , Rhomberg   PR., , Pfaller   MA., , Jones   RN. . Neisseria meningitidis with decreased susceptibility to penicillin: report from the SENTRY antimicrobial surveillance program, North America, 1998-99. . Diagn Microbiol Infect Dis . 2001; ;41: : 83– 88 .
    [Google Scholar]
  21. 21. Johnson   AW., , Adedoyin   OT., , Abdul-Karim   AA., , Olanrewaju   AW. . Childhood pyogenic meningitis: clinical and investigative indicators of etiology and outcome. . J Natl Med Assoc . 2007; ;99: : 937– 947 .
    [Google Scholar]
  22. 22. Chao   YN., , Chiu   NC., , Huang   FY. . Clinical features and prognostic factors in childhood pneumococcal meningitis. . J Microbiol Immunol Infect . 2008; ;41: : 48– 53 .
    [Google Scholar]
  23. 23. Proulx   N., , Frechette   D., , Toye   B., , Chan   J., , Kravcik   S. . Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. . QJM . 2005; ;98: : 291– 298 .
    [Google Scholar]
  24. 24. Elsaid   MF., , Falmerzi   AA., , Bessisso   MS., , Elshaffie   SS. . Acute bacterial meningitis in Qatar. . Saudi Med J . 2006; ;27: : 447– 453 .
    [Google Scholar]
  25. 25. Elsaid   MF., , Al Soub   H., , Bessisso   MS., , Elshaffie   SS. . Clinical presentation.of acute bacterial meningitis in Qatar. . Neurosciences . 2002; ;7: : 266– 271 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2010.2.9
Loading
  • Article Type: Research Article
Keyword(s): Meningitis , Meningococcal Meningitis , Meningococcemia and Neisseria Meningitidis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error